| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 1179.5 | 1074.6 | 871.6 |
| Other income | 16.4 | 9.7 | 7.1 |
| Total income | 1195.9 | 1084.3 | 878.7 |
| Profit before exceptional items & tax | 56.6 | 65.7 | 113.7 |
| Exceptional items | 0.0 | -10.9 | 0.0 |
| Profit before tax | 56.6 | 54.8 | 113.7 |
| Net profit | 37.4 | 33.1 | 85.0 |
| Operating margin | 4.7% | 5.1% | 12.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -56.00% |
|---|---|
| Net profit, quarter on quarter | +13.00% |
| Revenue, year on year | +35.30% |
| Operating profit, year on year | -73.00% |
| Operating profit, quarter on quarter | -10.30% |
NSE results filing, NSE: KIMS. Figures extracted from the filing.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹780.15
- Market cap
- ₹32,767 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 160.4×Sector 57.8×
- Promoter holding
- 32.50%-1.61% QoQ
- FII holding
- 14.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Share Pledge
Promoters pledged 2,80,08,979 equity shares (6.66%) to Catalyst Trusteeship as debenture trustee. The pledge secures existing debenture obligations with no new capital involved.
Krishna Institute of Medical Sciences Capacity Expansion
Krishna Institute of Medical Sciences Ltd entered an Operations and Management Agreement with Sarvottam Health Care Pvt Ltd for 5+5 years to manage their operations.
- Execution
- 5 years with an extension for a further period of 5 years
Krishna Institute of Medical Sciences Earnings Call Transcript: Key Takeaways
KIMS delivered strong EBITDA margins despite lower ARPOB compared to peers, driven by lean operational efficiency and high patient volumes.
Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways
KIMS reported strong Q1 FY27 results with consolidated operating revenue growth of 35.3% YoY and 9.8% QoQ, driven by expansion and higher occupancy in core clusters.
Krishna Institute of Medical Sciences Earnings Call: Key Takeaways
KIMS Hospitals Q4 FY26 earnings call highlighting robust 35.3% revenue growth to INR 1,084cr, despite EBITDA margin contraction to 19.9% due to heavy expansion and new unit drags.
Krishna Institute of Medical Sciences Earnings Call: Key Takeaways
KIMS delivered FY26 revenue growth of 28.2% YoY, reaching ₹39,308 Mn. Expansion continues across Telangana, AP, Maharashtra, and Kerala with a vision to reach 8600+ beds.